Segra International has announced a partnership with GreenBe Pharma, a premier European medicinal cannabis producer. This collaboration enables European cultivators to efficiently access Segra's renowned tissue culture cannabis clones through a localized European hub, significantly reducing the logistics and regulatory complexities often associated with international imports.
Under this arrangement, GreenBe Pharma becomes the central point of distribution for Segra's proprietary tissue culture clones throughout Europe. By sourcing these cultivars locally, growers can significantly shorten lead times, bypass cumbersome import procedures, and streamline overall operations to meet growing market demands.
"Partnering with GreenBe Pharma propels our mission to increase global accessibility to premium cannabis genetics," said Jamie Blundell, CEO of Segra International. "This alliance underscores our focus on quality and innovation, ensuring that European cultivators can elevate their operations while improving supply chain timelines."
"We are honored to collaborate with Segra International, a pioneer in tissue culture and cannabis genetics," said Eliecer López Jiménez, Business Development Manager at GreenBe Pharma. "By centralizing access to these premium genetics, we empower European cultivators to advance their capabilities and better provide starting material addressed to serve patient and consumer needs."
For more information:
Segra International Corp.
#108 – 21300 Gordon Way
Richmond, BC, Canada
segra-intl.com